$25 million pharmaceutical plant opens in Warsaw
KRKA Polska yesterday opened a pharmaceutical factory in Warsaw, where
production is due to kick off at the end of this year, with 3 types of
medicine being produced by next year. The cost of the factory has been
estimated at $25 million, resulting in company losses over recent years.
Joze Colaric, deputy general director of the Slovenian concern KRKA, said
that in 2001, KRKA Polska's revenues would increase by $5 million to $ 44
million, exceeding $50 million by 2003. Initially, KRKA Polska will employ
200 people. The firm will sell its products in Poland, the Baltic States and
Ukraine. According to Colaric, KRKA which has operated in Poland since 1974,
currently has around a 2% share in the Polish market. In related news,
Hungarian company Gedeon Richter has offered zl. 200 million for the
purchase of pharmaceutical plant Grodziskie Zaklady Farmaceutyczne (GZF).
(Prawo i Gospodarka, p. 3; Puls Biznesu, p.3 ). A.Z.
